Skye Bioscience, Inc. , a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases.
Skye Bioscience stock last closed at $0.88, down 1.68% from the previous day, and has decreased 59.68% in one year. It has underperformed other stocks in the Biotechnology industry by 0.47 percentage points. Skye Bioscience stock is currently +55.3% from its 52-week low of $0.57, and -84.71% from its 52-week high of $5.75.
As of Apr 30, 2026, there are 33.38M shares of SKYE outstanding. The market capitalization of SKYE is $29.34M. In the last 24 hours, 60,000 SKYE shares were traded.
You need a brokerage account to access the NASDAQ market and buy SKYE shares.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal details so you can buy SKYE today.
Now that you have filled out your info on our top ranked stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below for more details depositing money into your brokerage account.
After you have selected the best place to buy Skye Bioscience stock, it's crucial to analyze their stock prior to investing, so you can understand the risk as well as the opportunity.
WallStreetZen was designed to help part-time investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SKYE's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SKYE's fair value.
Using relative valuations ratios:
You can access additional valuation research on SKYE's stock here.
You can dive deeper into what analysts are projecting on the Skye Bioscience stock forecast page.
Over the past year, insiders at SKYE have sold more shares than they have bought.
5am Partners VII LLC, 10% Owner of SKYE, was the latest SKYE insider to sell. They sold $560,808.18 worth of SKYE shares on Aug 22, 2025.
Get more info about who owns SKYE shares here.
No, Skye Bioscience doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary options:
Hit the Open button and eToro will place the order.
If you need more help with investing in stocks on eToro, click the how to video below:
Now that you own some SKYE shares, you'll want to keep up with your new investment.
Create a watchlist to monitor your SKYE stock.
To reiterate, here are the 6 steps to buy stock in Skye Bioscience:
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to track your new investment in Skye Bioscience, add SKYE to your watchlist by clicking the button below.